Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Colorectal Cancer Metastatic × Immune Checkpoint Inhibitors × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2 Skin Neoplasms 1 Multiple Myeloma 1 Motor Activity 1 Melanoma 1 Leukemia, Myeloid, Acute 1 EBV-associated Tumors 1 Colorectal Cancer Metastatic 1 Carcinoma, Merkel Cell 1 Advanced Solid Tumor 1

Interventions

folfirinox 1 balstilimab 1 Immune Checkpoint Inhibitors 1 Folfox protocol 1 Doxorubicin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07486492 2026-03-20

Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer

The First Affiliated Hospital of Xiamen University

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡